ASX:EVN
ASX:EVNMetals and Mining

What Evolution Mining (ASX:EVN)'s Bigger Lithium Bet Means For Its Gold-Focused Shareholders

In late November 2025, Surge Battery Metals Inc., through its U.S. subsidiary, finalized all documents for a joint venture with an Evolution Mining Limited subsidiary to advance the Nevada North Lithium Project, and by mid-December Evolution had funded an initial CA$3,000,000, lifting its stake in Nevada North Lithium LLC to 25.85%. This move expands Evolution’s exposure beyond its core gold operations into lithium exploration, linking the group more directly to electric vehicle and battery...
ASX:ASX
ASX:ASXCapital Markets

Will Dee McGrath’s Appointment Reshape ASX’s (ASX:ASX) Technology and Governance Narrative?

ASX Limited has appointed Dee McGrath as a new non-executive director to its Board, effective 4 December 2025, continuing its Board renewal alongside recent additions Anne Loveridge AM and John Cincotta. With more than 30 years in global business, technology, and financial services, including leadership roles at MUFG, IBM, Visa and NAB, McGrath’s experience in large-scale transformations and regulatory change could influence how ASX approaches technology modernisation and governance in...
ASX:EOS
ASX:EOSAerospace & Defense

Is Electro Optic Systems (ASX:EOS) Quietly Reframing Its Defense Moat Through Counter-Drone Technology?

Electro Optic Systems Holdings recently took part in a Drone Conference, an industry gathering that showcased its counter-drone and related defense technologies to peers, customers, and analysts. This exposure can be important because such events often spotlight a company's innovation pipeline and market positioning, potentially reshaping how investors view its long-term role in unmanned systems. Now, we will explore how Electro Optic Systems Holdings’ Drone Conference participation could...
ASX:JHX
ASX:JHXBasic Materials

How Investors May Respond To James Hardie Industries (ASX:JHX) Revamping North American Leadership Ranks

Earlier this week, James Hardie Industries appointed Jonathan Skelly as President and General Manager of its North America Building Products Group and promoted long-time executive John Madson to Chief Sales Officer, while North America President Sean Gadd chose to leave the company. The leadership reshuffle hands James Hardie’s largest market to an external hire with deep experience at AZEK and Grainger, paired with an insider sales leader who has spent over two decades building the firm’s...
ASX:FMG
ASX:FMGMetals and Mining

How Investors Are Reacting To Fortescue (ASX:FMG) Doubling Down On Green Steel And Supply Chain Standards

In recent weeks, Fortescue Ltd expanded its green technology push by partnering with Taiyuan Iron and Steel Group on hydrogen-based plasma-enhanced low‑carbon steelmaking, while also updating investors at the Resourcing Tomorrow conference in London and issuing new employee incentive securities. Together with its latest Modern Slavery Statement and strengthened supply chain standards, these moves highlight Fortescue’s attempt to align long-term growth with decarbonisation and human rights...
ASX:LTR
ASX:LTRMetals and Mining

Liontown (ASX:LTR) Is Up 15.3% After Securing Canmax Offtake Deal – Has The Bull Case Changed?

Liontown Resources recently executed a binding offtake agreement with Canmax Technologies, under which it will supply 150,000 wet metric tonnes of spodumene concentrate annually during 2027 and 2028. This long-term supply commitment broadens Liontown’s customer base across geographies and the battery value chain, reinforcing its position in the global lithium materials market. We’ll now explore how this long-term Canmax offtake agreement may influence Liontown’s investment narrative,...
ASX:TLX
ASX:TLXBiotechs

Telix Pharmaceuticals (ASX:TLX) Valuation Check as ProstACT Global Phase 3 Trial Progresses to Part 2

Telix Pharmaceuticals (ASX:TLX) has dosed the first patient in Part 2 of its ProstACT Global Phase 3 trial for TLX591 in advanced prostate cancer, a key step that can reshape future value expectations. See our latest analysis for Telix Pharmaceuticals. This milestone comes after a tough stretch for investors, with the share price down sharply on a year to date basis even as the 3-year total shareholder return of 97.18 percent still points to strong long term wealth creation. This suggests...
ASX:WIA
ASX:WIAMetals and Mining

3 ASX Penny Stocks With Market Caps Under A$2B

Australian shares are poised for a robust start, with a projected 0.75% increase following the Federal Reserve's decision to trim U.S. rates for the third consecutive time. In this context, penny stocks—despite their somewhat outdated moniker—remain an intriguing investment area due to their potential for significant returns when backed by solid financials. This article explores three ASX penny stocks that exhibit strong financial foundations and could offer investors hidden value and growth...
ASX:MIN
ASX:MINMetals and Mining

Mineral Resources (ASX:MIN): Assessing Valuation After Strong Uptrend and Rising Investor Attention

Mineral Resources (ASX:MIN) has just popped up in a fresh ASX uptrend roundup, with its share price strength and technical signals putting it in the same conversation as the larger mining names. See our latest analysis for Mineral Resources. That recent breakout to A$51.63 caps a powerful run, with the 30 day share price return of 16.6 percent and 90 day share price return of 43.8 percent signalling momentum is building, even though the 3 year total shareholder return is still negative. If...
ASX:QBE
ASX:QBEInsurance

How QBE’s Tougher Climate Rules and Board Shift At QBE Insurance Group (ASX:QBE) Has Changed Its Investment Story

QBE Insurance Group has recently tightened climate requirements for its oil and gas clients, advanced its net zero commitments, continued expanding leadership in its UK casualty business, issued and converted 3,845 new ordinary shares, and announced that Non-Executive Director Peter Wilson will leave the board at the end of 2025 to join a competitor. Together, these moves highlight QBE’s push to sharpen climate risk oversight, deepen specialist underwriting capability in key markets, and...
ASX:ALL
ASX:ALLHospitality

Fitch Upgrade and Unsecured Structure Shift Could Be A Game Changer For Aristocrat Leisure (ASX:ALL)

Earlier in December 2025, Fitch Ratings upgraded Aristocrat Leisure’s Long-Term Issuer Default Ratings to ‘BBB’ from ‘BBB-’ with a Stable Outlook, reflecting its shift to an unsecured capital structure after repaying its term loan B. The upgrade underscores Fitch’s view that Aristocrat’s growing digital operations, strong credit metrics, and robust free cash flow generation support a more resilient balance sheet. We’ll now explore how this Fitch upgrade, particularly the move to an unsecured...
ASX:CSL
ASX:CSLBiotechs

Did Five-Year HEMGENIX Data Just Shift CSL's (ASX:CSL) Gene Therapy Investment Narrative?

CSL recently reported five-year Phase 3 HOPE-B data in NEJM and at the ASH meeting, showing HEMGENIX’s durable factor IX activity, sustained bleed reduction, and continued freedom from routine prophylaxis in adults with hemophilia B. The results reinforce HEMGENIX’s position as the only commercially available gene therapy for adult hemophilia B, with long-term safety and efficacy data that may shape how patients and clinicians view one-time gene therapy versus ongoing prophylaxis. We’ll now...